documents: FDA-2013-N-0500-0142
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2013-N-0500-0142 | FDA | FDA-2013-N-0500 | 02- Reference 01- Draft guidance for industry, “Updating ANDA Labeling After the Marketing Application for the Reference Listed Drug Has Been Withdrawn,” | Supporting & Related Material | Background Material | 2018-12-14T05:00:00Z | 2018 | 12 | 2018-12-14T15:13:06Z | 0 | 0 | 09000064839949a3 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref